BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30141907)

  • 1. Arsenic Exposure Contributes to the Bioenergetic Damage in an Alzheimer's Disease Model.
    Niño SA; Morales-Martínez A; Chi-Ahumada E; Carrizales L; Salgado-Delgado R; Pérez-Severiano F; Díaz-Cintra S; Jiménez-Capdeville ME; Zarazúa S
    ACS Chem Neurosci; 2019 Jan; 10(1):323-336. PubMed ID: 30141907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial Abnormalities and Synaptic Loss Underlie Memory Deficits Seen in Mouse Models of Obesity and Alzheimer's Disease.
    Martins IV; Rivers-Auty J; Allan SM; Lawrence CB
    J Alzheimers Dis; 2017; 55(3):915-932. PubMed ID: 27802235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related changes in core body temperature and activity in triple-transgenic Alzheimer's disease (3xTgAD) mice.
    Knight EM; Brown TM; Gümüsgöz S; Smith JC; Waters EJ; Allan SM; Lawrence CB
    Dis Model Mech; 2013 Jan; 6(1):160-70. PubMed ID: 22864021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
    Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
    Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the key molecules involved in chronic copper exposure-aggravated memory impairment in transgenic mice of Alzheimer's disease using proteomic analysis.
    Yu J; Luo X; Xu H; Ma Q; Yuan J; Li X; Chang RC; Qu Z; Huang X; Zhuang Z; Liu J; Yang X
    J Alzheimers Dis; 2015; 44(2):455-69. PubMed ID: 25352456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three month inhalation exposure to low-level PM2.5 induced brain toxicity in an Alzheimer's disease mouse model.
    Lee SH; Chen YH; Chien CC; Yan YH; Chen HC; Chuang HC; Hsieh HI; Cho KH; Kuo LW; Chou CC; Chiu MJ; Tee BL; Chen TF; Cheng TJ
    PLoS One; 2021; 16(8):e0254587. PubMed ID: 34437570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease.
    Halagappa VK; Guo Z; Pearson M; Matsuoka Y; Cutler RG; Laferla FM; Mattson MP
    Neurobiol Dis; 2007 Apr; 26(1):212-20. PubMed ID: 17306982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
    Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. iTRAQ analysis of complex proteome alterations in 3xTgAD Alzheimer's mice: understanding the interface between physiology and disease.
    Martin B; Brenneman R; Becker KG; Gucek M; Cole RN; Maudsley S
    PLoS One; 2008 Jul; 3(7):e2750. PubMed ID: 18648646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice.
    Nelson RL; Guo Z; Halagappa VM; Pearson M; Gray AJ; Matsuoka Y; Brown M; Martin B; Iyun T; Maudsley S; Clark RF; Mattson MP
    Exp Neurol; 2007 May; 205(1):166-76. PubMed ID: 17368447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurovascular uncoupling in the triple transgenic model of Alzheimer's disease: Impaired cerebral blood flow response to neuronal-derived nitric oxide signaling.
    Lourenço CF; Ledo A; Barbosa RM; Laranjinha J
    Exp Neurol; 2017 May; 291():36-43. PubMed ID: 28161255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDAC3 negatively regulates spatial memory in a mouse model of Alzheimer's disease.
    Zhu X; Wang S; Yu L; Jin J; Ye X; Liu Y; Xu Y
    Aging Cell; 2017 Oct; 16(5):1073-1082. PubMed ID: 28771976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralization of TNFSF10 ameliorates functional outcome in a murine model of Alzheimer's disease.
    Cantarella G; Di Benedetto G; Puzzo D; Privitera L; Loreto C; Saccone S; Giunta S; Palmeri A; Bernardini R
    Brain; 2015 Jan; 138(Pt 1):203-16. PubMed ID: 25472798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
    Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS
    Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease.
    Fragoulis A; Siegl S; Fendt M; Jansen S; Soppa U; Brandenburg LO; Pufe T; Weis J; Wruck CJ
    Redox Biol; 2017 Aug; 12():843-853. PubMed ID: 28448946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective Effects of Icariin on Brain Metabolism, Mitochondrial Functions, and Cognition in Triple-Transgenic Alzheimer's Disease Mice.
    Chen YJ; Zheng HY; Huang XX; Han SX; Zhang DS; Ni JZ; He XY
    CNS Neurosci Ther; 2016 Jan; 22(1):63-73. PubMed ID: 26584824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Intervention with a Multi-Ingredient Dietary Supplement Improves Mood and Spatial Memory in a Triple Transgenic Mouse Model of Alzheimer's Disease.
    Hutton CP; Lemon JA; Sakic B; Rollo CD; Boreham DR; Fahnestock M; Wojtowicz JM; Becker S
    J Alzheimers Dis; 2018; 64(3):835-857. PubMed ID: 29914019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice.
    Adegoke OO; Qiao F; Liu Y; Longley K; Feng S; Wang H
    J Alzheimers Dis; 2017; 59(2):575-590. PubMed ID: 28598849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.